INOVIO PHARMACEUTICALS, INC. — Director's Dealing 2008

Feb 1, 2008

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INOVIO BIOMEDICAL CORP (INO)
CIK: 0001055726
Period of Report: 2008-02-01

Reporting Person: DHILLON PUNIT (VP, Finance & Operations)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2008-02-01	Common Stock Option	$0.87	A	50000	Acquired	2018-02-01	Common Stock (50000)	Direct

Footnotes

F1: The vesting schedule for the 50,000 options is as follows: 12,500 shares will vest on February 1, 2008; 12,500 shares will vest on February 1, 2009; 12,500 shares will vest on February 1, 2010; 12,500 shares will vest on February 1, 2011.